1. Abdominal Visceral Infarction in 3 Patients with COVID-19.
- Author
-
Besutti G, Bonacini R, Iotti V, Marini G, Riva N, Dolci G, Maiorana M, Spaggiari L, Monelli F, Ligabue G, Guaraldi G, Rossi PG, Pattacini P, and Massari M
- Subjects
- Abdomen blood supply, Abdomen pathology, Abdomen virology, Aged, Antiviral Agents therapeutic use, Betacoronavirus drug effects, COVID-19, Coronavirus Infections diagnostic imaging, Coronavirus Infections therapy, Coronavirus Infections virology, Drug Combinations, Humans, Hydroxychloroquine therapeutic use, Infarction diagnostic imaging, Infarction therapy, Infarction virology, Italy, Lopinavir therapeutic use, Male, Middle Aged, Pandemics, Pneumonia, Viral diagnostic imaging, Pneumonia, Viral therapy, Pneumonia, Viral virology, Ritonavir therapeutic use, SARS-CoV-2, Thrombosis diagnostic imaging, Thrombosis therapy, Thrombosis virology, Tomography, X-Ray Computed, Viscera blood supply, Viscera drug effects, Viscera pathology, Viscera virology, Anticoagulants therapeutic use, Betacoronavirus pathogenicity, Coronavirus Infections complications, Heparin, Low-Molecular-Weight therapeutic use, Infarction complications, Pneumonia, Viral complications, Thrombosis complications
- Abstract
A high incidence of thrombotic events has been reported in patients with coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We report 3 clinical cases of patients in Italy with COVID-19 who developed abdominal viscera infarction, demonstrated by computed tomography.
- Published
- 2020
- Full Text
- View/download PDF